The Acessa Procedure – Results
- Addresses nearly all symptoms such as excessive bleeding, prolonged periods, urinary frequency, painful sex, stomach, lower-back and pelvic pain. Individual results vary based.
- In clinical studies, there was an average shrinkage of 45% in fibroid size post-procedure. This number is contingent on where the fibroid is located and the size.
- Women typically see the most symptom improvement within 3 months of the procedure with continued improvement throughout the first year.
- Studies have shown both clinically and statistically significant reduction in period blood loss.
- Significant reduction in fibroid and uterine volume.
BY THE NUMBERS:
- 82% of women had lighter periods.
- 94% patient satisfaction rate.
- Only 11% of patients required additional reintervention after the Acessa procedure.
Why haven’t I heard of Acessa before? Is it brand new?
Laparoscopic RFA was first performed on fibroids in 1999 by Dr. Bruce Lee. (2) After many successful studies, the original Acessa System was FDA cleared in November 2012. Since 2012, physicians have performed over 3,000 procedures to date.(5) The newest, most advanced technology, the Acessa ProVu system, was FDA cleared in 2018.
Your physician can explain the potential complications of the Acessa Procedure, as well as those of other available fibroid therapies.
Is it covered by insurance?
Acessa is covered by many insurance carriers. The first step if you are interested in Acessa is to contact a physician who offers Acessa and schedule an initial consultation. After you have a consultation with a physician and determine if you are a candidate for the procedure, they can help you understand the benefits and coverage for Acessa.
Acessa Health does not make any recommendations, referrals, or endorsements regarding specific physicians with whom patients may seek treatment, nor does this site serve as a tool for verification of a specific surgeon’s credentials, qualifications, or abilities. Only a trained physician is qualified to recommend treatments and/or make diagnoses. You assume full responsibility for your communications and interactions made with any physician you choose to contact from the use of this website.
Acessa is cleared by the FDA for the treatment of symptomatic uterine fibroids. There are risks associated with all minimally invasive surgical procedures, including serious complications such as infection, bowel injury, and postoperative bleeding. Insufficient data exist on which to evaluate the safety and effectiveness of Acessa procedure in women who plan future pregnancy. Therefore, the Acessa procedure is not recommended for women who are planning future pregnancy. Please consult with an Acessa-trained gynecologist to understand the risks of surgery and find out if Acessa may be right for you.